City Insurance PLC. (DSE:CITYGENINS)

City Insurance PLC. Statistics

Total Valuation

DSE:CITYGENINS has a market cap or net worth of BDT 2.24 billion. The enterprise value is 1.25 billion.

Market Cap	2.24B
Enterprise Value	1.25B

Important Dates

The next estimated earnings date is Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	Mar 2, 2025

Share Statistics

DSE:CITYGENINS has 68.17 million shares outstanding. The number of shares has increased by 0.34% in one year.

Current Share Class	n/a
Shares Outstanding	68.17M
Shares Change (YoY)	+0.34%
Shares Change (QoQ)	-0.66%
Owned by Insiders (%)	35.73%
Owned by Institutions (%)	n/a
Float	43.58M

Valuation Ratios

The trailing PE ratio is 10.07.

PE Ratio	10.07
Forward PE	n/a
PS Ratio	2.81
PB Ratio	1.52
P/TBV Ratio	1.52
P/FCF Ratio	14.96
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.82, with an EV/FCF ratio of 8.36.

EV / Earnings	5.62
EV / Sales	1.57
EV / EBITDA	3.82
EV / EBIT	3.93
EV / FCF	8.36

Financial Position

The company has a current ratio of 3.39

Current Ratio	3.39
Quick Ratio	2.81
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 15.54% and return on invested capital (ROIC) is 13.90%.

Return on Equity (ROE)	15.54%
Return on Assets (ROA)	9.42%
Return on Invested Capital (ROIC)	13.90%
Return on Capital Employed (ROCE)	18.79%
Revenue Per Employee	3.52M
Profits Per Employee	982,534
Employee Count	227
Asset Turnover	0.38
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.95% in the last 52 weeks. The beta is 0.79, so DSE:CITYGENINS's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-60.95%
50-Day Moving Average	37.42
200-Day Moving Average	55.98
Relative Strength Index (RSI)	25.01
Average Volume (20 Days)	84,981

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:CITYGENINS had revenue of BDT 798.70 million and earned 223.04 million in profits. Earnings per share was 3.27.

Revenue	798.70M
Gross Profit	578.27M
Operating Income	319.09M
Pretax Income	316.39M
Net Income	223.04M
EBITDA	327.64M
EBIT	319.09M
Earnings Per Share (EPS)	3.27

Balance Sheet

The company has 989.61 million in cash and n/a in debt, giving a net cash position of 989.61 million or 14.52 per share.

Cash & Cash Equivalents	989.61M
Total Debt	n/a
Net Cash	989.61M
Net Cash Per Share	14.52
Equity (Book Value)	1.48B
Book Value Per Share	21.68
Working Capital	1.13B

Cash Flow

In the last 12 months, operating cash flow was 152.19 million and capital expenditures -2.28 million, giving a free cash flow of 149.91 million.

Operating Cash Flow	152.19M
Capital Expenditures	-2.28M
Free Cash Flow	149.91M
FCF Per Share	2.20

Margins

Gross margin is 72.40%, with operating and profit margins of 39.95% and 27.92%.

Gross Margin	72.40%
Operating Margin	39.95%
Pretax Margin	39.61%
Profit Margin	27.92%
EBITDA Margin	41.02%
EBIT Margin	39.95%
FCF Margin	18.77%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 3.00%.

Dividend Per Share	1.00
Dividend Yield	3.00%
Dividend Growth (YoY)	-16.67%
Years of Dividend Growth	2
Payout Ratio	36.68%
Buyback Yield	-0.34%
Shareholder Yield	2.66%
Earnings Yield	9.95%
FCF Yield	6.68%

Stock Splits

The last stock split was on April 30, 2018. It was a forward split with a ratio of 1.1.

Last Split Date	Apr 30, 2018
Split Type	Forward
Split Ratio	1.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a